We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 7.84% | 1.65 | 1.60 | 1.70 | 1.725 | 1.50 | 1.50 | 48,827,665 | 16:01:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.37 | 1.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2021 06:40 | Bunz Aka Sharehunter , everyone knows is a paid RAMPER | oilisgold | |
11/2/2021 06:40 | blah blah blah no, you are the going concern you twit...you sound so desperate. Don't tell me you have got a short on here? | jambam | |
11/2/2021 06:39 | Same as last time. Will be pumped to 300p then the dump again | oilisgold | |
11/2/2021 06:38 | That was from Nov RNS, the Rampers have got rose tinted specs on | oilisgold | |
11/2/2021 06:38 | Looks like placing on the way to me. | oilisgold | |
11/2/2021 06:37 | Going concern We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going concern. | oilisgold | |
10/2/2021 23:50 | In case anyone needs reminding: "genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive(R) 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit. The Genedrive(R) 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument." | aquilla | |
10/2/2021 23:40 | From the LSE site: "Good news. Looks like the new fully automated Bio meks are already getting rolled out to help the lab technicians across the USA. ALSO looks like demand is through the roof!!! "We put the order in two months before we got it,” she said. “The day after we placed the order, the company told us if we hadn’t ordered it then, we would have had another several months of wait time. "The whole country is looking for automation" THE WHOLE COUNTRY THE WHOLE OF THE USA" | aquilla | |
10/2/2021 22:47 | oilisgold, sad to see any one posting the posts you posting about this share peoplehave posted the money gdr have and peoplwe have also posted gdr have no debt so you not fool any one who has done their research you might try and get less experienced investors to sell hope other investors as well as myself will post and try and help other people not to be mislead ,all investors do your own research ,d y o r | bunz3 | |
10/2/2021 22:35 | Placing on its way. | oilisgold | |
10/2/2021 22:34 | Basically company has run out of cash. | oilisgold | |
10/2/2021 22:34 | are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going | oilisgold | |
10/2/2021 22:23 | oilisgold+. you trying so hard to damage this share price people can see through your posting no matter how many posts you post night and day deramping gdr the buyers still loading up as many of them have done their research and read the rns | bunz3 | |
10/2/2021 22:05 | Put Oily on filter. A waste of space. You will be better for it. Ignore it. | sellsell | |
10/2/2021 21:28 | Like it was pumped to 300p. Rinse and repeat | oilisgold | |
10/2/2021 21:28 | I warned you all, this was being pumped for a placing. | oilisgold | |
10/2/2021 21:27 | That was few months ago. Placing has been in discussion at 50p. | oilisgold | |
10/2/2021 21:26 | We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going | oilisgold | |
10/2/2021 21:17 | You cant rns lies son.I suggest you are bitter through loosing money somewhere....just get over it and move on. | countdracula55 | |
10/2/2021 21:15 | Lol. Amigo | professor_advfn | |
10/2/2021 21:15 | Beckman RNS was just to pump this share up again | oilisgold | |
10/2/2021 21:14 | Amaretto, well done for not buying. This will end in tears for many. REMEMBER THE LAST PUMP TO 300P AND THE DUMP TO 40P. | oilisgold | |
10/2/2021 20:24 | A big RNS expected next week on Beckman sales | swerves1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions